Health Care Company Coherus BioSciences Announces Merger With Surface Oncology
Health Care Company Coherus BioSciences Announces Merger With Surface Oncology
Coherus BioSciences (NASDAQ:CHRS) has announced a merger with Surface Oncology (NASDAQ:SURF) that is expected to be completed in Q3 of 2023.
Coherus 生物科学 纳斯达克股票代码：CHRS）宣布与合并 表面肿瘤学 （纳斯达克股票代码：SURF）预计将于2023年第三季度完工。
Under the terms of the agreement, Coherus BioSciences has agreed to give Surface Oncology $40.00 million in in exchange for SURF stock. Currently, neither company has disclosed whether the paymentwill be in cash or in stock.
根据协议条款，Coherus BioSciences已同意向Surface Oncology提供4,000万美元，以换取SURF股票。目前，两家公司都没有透露这笔款项是现金还是股票。
About The Companies Involved
关于所涉公司
Coherus BioSciences Inc is a commercial-stage biopharmaceutical company building an innovative immuno-oncology franchise funded with cash generated by its diversified portfolio of FDA-approved therapeutics. Toripalimab is being evaluated in pivotal clinical trials for the treatment of cancers of the lung, breast, liver, skin, kidney, stomach, esophagus, and bladder.
Coherus BioSciences Inc是一家处于商业阶段的生物制药公司，正在建立创新的免疫肿瘤学特许经营权，资金来自其经美国食品药品管理局批准的多元化疗法组合产生的现金。Toripalimab正在对治疗肺癌、乳腺癌、肝癌、皮肤癌、肾癌、胃癌、食道癌和膀胱癌的关键临床试验进行评估。
Surface Oncology Inc is a clinical-stage immuno-oncology company. It is developing new therapies that modify the spaces in and around tumors in the tumor microenvironment to create conditions that support and sustain anti-tumor immune responses.
Surface Oncology Inc是一家处于临床阶段的免疫肿瘤学公司。它正在开发新的疗法，改变肿瘤微环境中肿瘤内部和周围的空间，为支持和维持抗肿瘤免疫反应创造条件。
How A Merger Works
合并是如何运作的
A merger happens when a company combines operations with another company. In practice, one company will buy the other company's stock in exchange for its own stock. In some cases, cash is used to pay for the company's stock but usually the companies agree to a stock-for-stock transaction.
当一家公司与另一家公司合并业务时，就会发生合并。实际上，一家公司将购买另一家公司的股票以换取自己的股票。在某些情况下，现金用于支付公司的股票，但通常公司同意以股换股的交易。
Due to the exchange and acquisition of stock, a merger is similar to an acquisition. This is why the two terms are commonly grouped together as mergers and acquisitions (M&A). However, in a merger, the leadership & operations of both companies usually change dramatically, while during an acquisition this is less likely to happen.
由于股票的交换和收购，合并类似于收购。这就是为什么这两个术语通常归为合并和收购（M&A）的原因。但是，在合并中，两家公司的领导层和运营通常会发生巨大变化，而在收购期间，这种情况发生的可能性较小。
Make sure to follow our mergers & acquisitions calendar to stay-up-to-date on the most recent M&A deals.
一定要 关注我们的并购日历 随时了解最新的并购交易。
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自动内容引擎生成，并由编辑审阅。